Australia - English - Department of Health (Therapeutic Goods Administration)

swisse wellness pty ltd - dimethyl sulfone, quantity: 500 mg; curcuma longa, quantity: 25 mg (equivalent: curcuma longa, qty 500 mg; equivalent: curcuminoids (of curcuma longa), qty 16.25 mg); glucosamine sulfate sodium chloride, quantity: 628.61 mg (equivalent: glucosamine sulfate, qty 500 mg) - tablet, film coated - excipient ingredients: silicon dioxide; croscarmellose sodium; titanium dioxide; maltodextrin; carnauba wax; hypromellose; magnesium stearate; iron oxide yellow; povidone; colloidal anhydrous silica; microcrystalline cellulose; macrogol 8000; crospovidone; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support general health and wellbeing ; helps decrease/reduce/relieve cartilage loss/wear/tear/damage ; decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis ; helps maintain/support joint cartilage health ; traditionally used in western herbal medicine to maintain/support joint health ; maintain/support joint health ; decrease/reduce/relieve mild joint inflammation/swelling ; traditionally used in western herbal medicine to decrease/reduce/relieve mild joint inflammation/swelling ; maintain/support joint mobility/flexibility ; decrease/reduce/relieve mild joint pain/soreness ; traditionally used in western herbal medicine to decrease/reduce/relieve mild joint pain/soreness ; decrease/reduce/relieve mild joint stiffness

Australia - English - Department of Health (Therapeutic Goods Administration)

swisse wellness pty ltd - curcuma longa, quantity: 25 mg (equivalent: curcuma longa, qty 500 mg; equivalent: curcuminoids (of curcuma longa), qty 16.25 mg); dimethyl sulfone, quantity: 500 mg; glucosamine sulfate sodium chloride, quantity: 628.61 mg (equivalent: glucosamine sulfate, qty 500 mg) - tablet, film coated - excipient ingredients: silicon dioxide; sodium; povidone; microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; crospovidone; magnesium stearate; carnauba wax; hypromellose; macrogol 8000; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - supports healthy knee, joint health & mobility anti-inflammatory joint cartilage health: glucosamine supports joint cartilage health. joint health & mobility: glucosamine sulfate supports joint health and mobility. antioxidant: turmeric provides antioxidants that help reduce free radical damage to body cells and supports general health & wellbeing.

Israel - English - Ministry of Health

teva israel ltd - dimethyl fumarate - gastro resistant hard capsule - dimethyl fumarate 240 mg - dimethyl fumarate - dimethyl fumarate teva is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis

Israel - English - Ministry of Health

teva israel ltd - dimethyl fumarate - gastro resistant hard capsule - dimethyl fumarate 120 mg - dimethyl fumarate - dimethyl fumarate teva is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis

European Union - English - EMA (European Medicines Agency)

mylan ireland limited - dimethyl fumarate - multiple sclerosis, relapsing-remitting - immunosuppressants - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

European Union - English - EMA (European Medicines Agency)

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethyl fumarate - multiple sclerosis, relapsing-remitting - immunosuppressants - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

European Union - English - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimethyl fumarate - multiple sclerosis, relapsing-remitting - immunosuppressants - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

European Union - English - EMA (European Medicines Agency)

teva gmbh - dimethyl fumarate - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressants - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

European Union - English - EMA (European Medicines Agency)

accord healthcare s.l.u. - dimethyl fumarate - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressants - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Australia - English - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - dimethyl fumarate, quantity: 240 mg - capsule, enteric - excipient ingredients: magnesium stearate; titanium dioxide; croscarmellose sodium; microcrystalline cellulose; methacrylic acid copolymer; colloidal anhydrous silica; triethyl citrate; methacrylic acid - ethyl acrylate copolymer (1:1); gelatin; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - dimethyl fumarate msn is indicated in patients with relapsing multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.